Submitted by obuadmin on
Guidelines on the clinical indications for blood component transfusion should generally be available for clinical situations relevant to the hospital’s clinical activities, see the Transfusion section of this site.
Table 5.1 Hospital blood banks should have SOPs for:
Procedure or process | Use this space to note reference to local procedure or relevant example |
---|---|
Stock inventory management | |
Receipt of blood samples | |
Pretransfusion testing | |
Issue of blood components | |
Emergency supply of blood components | |
Adverse reaction/event reporting | |
Traceability of blood components | |
Blood components: essential information for clinicians |
Table 5.2 Agreement between blood establishment and hospital blood bank should include
Procedure or process | Use this space to note reference to local procedure or relevant example |
---|---|
Ordering blood components from the Blood Establishment | |
Storage and transport of blood components | |
Checking the quality of blood components at receipt | |
Stock Management | |
Traceability of blood components | |
Haemovigilance |
Table 5.3 Hospital blood banks and clinical units should have SOPs for these aspects of the clinical transfusion process:
Procedure or process | Use this space to note reference to local procedure or relevant example |
---|---|
Assessing the need for blood component therapy | |
Patient information and documenting consent from the patient | |
Taking blood samples for pretransfusion testing | |
Making the request for blood components | |
Surgical Blood Ordering Schedule | |
Ordering, pretransfusion testing, issue and delivery of blood components
|
|
Transportation of blood samples to the Hospital Blood Bank | |
Acceptance criteria for samples received in the laboratory | |
Thawing of FFP | |
Transportation of blood components | |
Pre-administration checks and bedside tests | |
Selection and use of infusion devices (e.g. rapid infusion, neonatal transfusion) | |
Setting up the transfusion, administering, transfusion rates | |
Warming infusion fluids including blood | |
Baseline observation and monitoring of the patient | |
Management of adverse reactions | |
Traceability of blood components |